Cargando…

Drugs Modulating CD4+ T Cells Blood–Brain Barrier Interaction in Alzheimer’s Disease

The effect of Alzheimer’s disease (AD) medications on CD4+ T cells homing has not been thoroughly investigated. CD4+ T cells could both exacerbate and reduce AD symptoms based on their infiltrating subpopulations. Proinflammatory subpopulations such as Th1 and Th17 constitute a major source of proin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kubick, Norwin, Flournoy, Patrick C. Henckell, Enciu, Ana-Maria, Manda, Gina, Mickael, Michel-Edwar
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7558445/ https://www.ncbi.nlm.nih.gov/pubmed/32948022 http://dx.doi.org/10.3390/pharmaceutics12090880

Ejemplares similares

What has single‐cell RNA sequencing revealed about microglial neuroimmunology?
por: Kubick, Norwin, et al.
Publicado: (2020)

Paracellular and Transcellular Leukocytes Diapedesis Are Divergent but Interconnected Evolutionary Events
por: Mickael, Michel-Edwar, et al.
Publicado: (2021)

Interleukins and Interleukin Receptors Evolutionary History and Origin in Relation to CD4+ T Cell Evolution
por: Kubick, Norwin, et al.
Publicado: (2021)

CD4(+) Tregs may be essential for solving astrocyte glial scar deadlock
por: Edwar-Mickael, Michel, et al.
Publicado: (2021)

Repurposing Zileuton as a Depression Drug Using an AI and In Vitro Approach
por: Kubick, Norwin, et al.
Publicado: (2020)

Investigation of Evolutionary History and Origin of the Tre1 Family Suggests a Role in Regulating Hemocytes Cells Infiltration of the Blood–Brain Barrier
por: Kubick, Norwin, et al.
Publicado: (2021)

Molecular Evolution and Functional Divergence of the IgLON Family
por: Kubick, Norwin, et al.
Publicado: (2018)

Investigation of the Molecular Evolution of Treg Suppression Mechanisms Indicates a Convergent Origin
por: Bhaumik, Suniti, et al.
Publicado: (2023)

Trends of Anger and Physical Aggression in Russian Women During COVID-19 Lockdown
por: Klimovich-Mickael, Alexandra, et al.
Publicado: (2021)

Investigation of Mutated in Colorectal Cancer (MCC) Gene Family Evolution History Indicates a Putative Role in Th17/Treg Differentiation
por: Kubick, Norwin, et al.
Publicado: (2023)

Triggers and Effectors of Oxidative Stress at Blood-Brain Barrier Level: Relevance for Brain Ageing and Neurodegeneration
por: Enciu, Ana-Maria, et al.
Publicado: (2013)

The blood-brain barrier in Alzheimer's disease
por: Zenaro, Elena, et al.
Publicado: (2017)

Interaction of amisulpride with GLUT1 at the blood-brain barrier. Relevance to Alzheimer’s disease
por: Boyanova, Sevda T., et al.
Publicado: (2023)

Blood–brain-barriers in aging and in Alzheimer’s disease
por: Marques, Fernanda, et al.
Publicado: (2013)

Dyslipidemia and Blood-Brain Barrier Integrity in Alzheimer's Disease
por: Bowman, Gene L., et al.
Publicado: (2012)

Disruption of blood-brain barrier in Alzheimer disease pathogenesis
por: Kook, Sun-Young, et al.
Publicado: (2013)

Blood-Brain Barrier Dysfunction and the Pathogenesis of Alzheimer’s Disease
por: Yamazaki, Yu, et al.
Publicado: (2017)

Addressing Blood–Brain Barrier Impairment in Alzheimer’s Disease
por: Sharma, Chanchal, et al.
Publicado: (2022)

Modulation of the Blood–Brain Barrier for Drug Delivery to Brain
por: Han, Liang
Publicado: (2021)

Increased MYD88 blood transcript in a mouse model of Alzheimer’s disease
por: Cucos, Catalina Anca, et al.
Publicado: (2022)

The Blood-Brain Barrier and Microvascular Water Exchange in Alzheimer's Disease
por: Anderson, Valerie C., et al.
Publicado: (2011)

Alzheimer’s disease: A matter of blood–brain barrier dysfunction?
por: Montagne, Axel, et al.
Publicado: (2017)

Treatment of Alzheimer’s Disease and Blood–Brain Barrier Drug Delivery
por: Pardridge, William M.
Publicado: (2020)

Blood–Brain Barrier Breakdown in Relationship to Alzheimer and Vascular Disease
por: Lin, Zixuan, et al.
Publicado: (2021)

Discerning the Role of Blood Brain Barrier Dysfunction in Alzheimer’s Disease
por: Tao, Qing-Qing, et al.
Publicado: (2022)

Imaging blood–brain barrier disruption in neuroinflammation and Alzheimer’s disease
por: Lee, Rae-Ling, et al.
Publicado: (2023)

Endothelial genetic deletion of CD147 induces changes in the dual function of the blood‐brain barrier and is implicated in Alzheimer’s disease
por: Wang, Hao, et al.
Publicado: (2021)

Altered Blood and Brain Expression of Inflammation and Redox Genes in Alzheimer’s Disease, Common to APP(V717I) × TAU(P301L) Mice and Patients
por: Cucos, Catalina Anca, et al.
Publicado: (2022)

The Role of the Blood-Brain Barrier in the Pathogenesis of Senile Plaques in Alzheimer's Disease
por: Provias, J., et al.
Publicado: (2014)

Blood Brain Barrier and Alzheimer’s Disease: Similarity and Dissimilarity of Molecular Alerts
por: Toropova, Alla P., et al.
Publicado: (2018)

Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders
por: Uchida, Yuto, et al.
Publicado: (2023)

Blood–Brain Barrier Breakdown in Alzheimer’s Disease: Mechanisms and Targeted Strategies
por: Alkhalifa, Amer E., et al.
Publicado: (2023)

Modulating the Blood–Brain Barrier: A Comprehensive Review
por: Whelan, Rory, et al.
Publicado: (2021)

Brain ischemia and ischemic blood–brain barrier as etiological factors in sporadic Alzheimer’s disease
por: Pluta, Ryszard, et al.
Publicado: (2008)

The Blood−Brain Barrier in Neuroimmune Interactions and Pathological Processes
por: Dyatlova, A. S., et al.
Publicado: (2022)

An Update on the Evolutionary History of Bregs
por: Mickael, Michel-Edwar, et al.
Publicado: (2022)

Borneol and Tetrandrine Modulate the Blood–Brain Barrier and Blood–Tumor Barrier to Improve the Therapeutic Efficacy of 5-Fluorouracil in Brain Metastasis
por: Lin, Jui-Feng, et al.
Publicado: (2022)

Developing drugs that can cross the blood-brain barrier: applications to Alzheimer's disease
por: Banks, William A
Publicado: (2008)

Mast Cells in Stress, Pain, Blood-Brain Barrier, Neuroinflammation and Alzheimer’s Disease
por: Kempuraj, Duraisamy, et al.
Publicado: (2019)

Blood-brain barrier–penetrating siRNA nanomedicine for Alzheimer’s disease therapy
por: Zhou, Yutong, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_f5sslsnn7bamp7f7u49o5befh7